Skip to content

Integrating clinical studies and Patient Support Programs(PSPs) for holistic rare disease care

In our latest expert guide, we explore the potential integration of clinical studies with patient support programs. A move which could enhance the depth and quality of your real-world data and give patients easier access to new life-changing treatments.

Detailing the advantages and challenges of this holistic approach, the article covers:  

  • The current challenges of rare disease clinical trials
  • The key role of Early Access Programs and Observational Studies
  • The benefits of Patient Support Programs
  • The potential of a new holistic approach: integrating clinical studies and PSPs
Consent(Required)
This field is for validation purposes and should be left unchanged.